| Pro-inflammatory cytokines: The link between obesity and osteoarthritis |
51 |
| The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine |
29 |
| Armed oncolytic viruses: A kick-start for anti-tumor immunity |
25 |
| Adiponectin: A potential therapeutic target for metabolic syndrome |
25 |
| Autophagy and proinflammatory cytokines: Interactions and clinical implications |
23 |
| IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets |
23 |
| Pathological roles of the homeostatic chemokine CXCL12 |
21 |
| TGF-beta and mesenchymal stromal cells in regenerative medicine, autoimmunity and cancer |
19 |
| The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators |
19 |
| IL-23 in inflammatory bowel diseases and colon cancer |
18 |
| CD14: Biology and role in the pathogenesis of disease |
18 |
| The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer |
16 |
| Natural killer cells in inflammation and autoimmunity |
16 |
| Clinical implications of macrophage dysfunction in the development of osteoarthritis of the knee |
14 |
| Novel activators and small-molecule inhibitors of STAT3 in cancer |
13 |
| Multilayered and versatile inhibition of cellular antiviral factors by HIV and SIV accessory proteins |
13 |
| Interleukin-13: A promising therapeutic target for autoimmune disease |
12 |
| Lymphoid tissue inducer-A divergent member of the ILC family |
11 |
| Dermal fibroblasts-A heterogeneous population with regulatory function in wound healing |
11 |
| Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis |
10 |
| Mesenchymal stem cells immunomodulation: The road to IFN-gamma licensing and the path ahead |
10 |
| The role of the IL-33/ST2 axis in autoimmune disorders: Friend or foe? |
10 |
| Role of the PI3K/AKT (mTOR and GSK3 beta) signalling pathway and photobiomodulation in diabetic wound healing |
10 |
| The tolerogenic role of IFN-gamma |
9 |
| Synergy of Interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases |
9 |
| Cytokines in the pathogenesis of hemophilic arthropathy |
9 |
| The potential of adipokines as biomarkers and therapeutic agents for vascular complications in type 2 diabetes mellitus |
9 |
| Progranulin: A conductor of receptors orchestra, a chaperone of lysosomal enzymes and a therapeutic target for multiple diseases |
8 |
| Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome |
8 |
| The enigmatic role of IL-38 in inflammatory diseases |
8 |
| Potential role of melatonin in autoimmune diseases |
8 |
| The role of the common gamma-chain family cytokines in gamma delta T cell-based anti-cancer immunotherapy |
7 |
| Collagen and non-collagenous proteins molecular crosstalk in the pathophysiology of osteoporosis |
7 |
| Transcriptional and chromatin regulation in interferon and innate antiviral gene expression |
7 |
| Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infection |
7 |
| The dynamic interactions between the stroma, pancreatic stellate cells and pancreatic tumor development: Novel therapeutic targets |
7 |
| Emerging role of immune cell network in autoimmune skin disorders: An update on pemphigus, vitiligo and psoriasis |
7 |
| Let me in: Control of HIV nuclear entry at the nuclear envelope |
7 |
| Augmenter of liver regeneration: Essential for growth and beyond |
6 |
| Architecture of antimicrobial skin defense |
6 |
| Dual faced HMGB1 plays multiple roles in cardiomyocyte senescence and cardiac inflammatory injury |
6 |
| Insulin-like growth factor binding proteins and angiogenesis: from cancer to cardiovascular disease |
6 |
| Elabela and Apelin actions in healthy and pathological pregnancies |
6 |
| Innate lymphoid cells in organ fibrosis |
6 |
| The physiopathologic interplay between stem cells and tissue niche in muscle regeneration and the role of IL-6 on muscle homeostasis and diseases |
6 |
| Inflammation-induced metabolic derangements or adaptation: An immunometabolic perspective |
5 |
| Potential roles of IL-1 subfamily members in glycolysis in disease |
5 |
| Novel non-angiogenic role for mesenchymal stem cell-derived vascular endothelial growth factor on keratinocytes during wound healing |
5 |
| Mechanistic insights into the protective impact of zinc on sepsis |
5 |
| Folate-targeted immunotherapies: Passive and active strategies for cancer |
5 |
